Zhejiang Orient Gene Biotech Co Ltd (688298) — Cash Flow Quality Index
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow Quality Index of -5.35x as of June 2023. Operating cash flow of CN¥-455.48 Million is below net income of CN¥85.14 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688298 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Orient Gene Biotech Co Ltd Cash Flow Quality Index (2016–2022)
Historical Cash Flow Quality Index for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Zhejiang Orient Gene Biotech Co Ltd (688298) cash conversion ratio.
Annual Cash Flow Quality Index for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Year-by-year earnings quality comparison for Zhejiang Orient Gene Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.43x | CN¥3.00 Billion | CN¥2.10 Billion | ▲ +35.6% |
| 2021 | 1.05x | CN¥5.20 Billion | CN¥4.94 Billion | ▼ -1.1% |
| 2020 | 1.07x | CN¥1.79 Billion | CN¥1.68 Billion | ▲ +52.3% |
| 2019 | 0.70x | CN¥54.21 Million | CN¥77.51 Million | ▲ +0.9% |
| 2018 | 0.69x | CN¥44.33 Million | CN¥63.96 Million | ▼ -32.4% |
| 2017 | 1.03x | CN¥33.54 Million | CN¥32.71 Million | ▲ +209.4% |
| 2016 | 0.33x | CN¥11.81 Million | CN¥35.63 Million | — |